The healthcare sector in India is growing like never before, and regional hospital chains are quietly becoming powerful investment opportunities. One such upcoming issue creating buzz in the primary market is the Gujarat Kidney and Super Speciality IPO.
This IPO gives investors a chance to participate in a fast-expanding regional healthcare provider with a strong presence in Gujarat.
In this detailed article, we will break down everything you need to know—GMP, IPO price, dates, financials, strengths, risks, allotment details, and whether this IPO is worth subscribing to.
About Gujarat Kidney and Super Speciality Limited
Gujarat Kidney and Super Speciality Limited is a regional healthcare provider headquartered in central Gujarat. As of 20 March 2025, the company operates:
-
- 6 multispeciality hospitals
-
- 3 in-house pharmacies
The hospitals are strategically located in Vadodara, Godhra, Bharuch, Borsad, and Anand, catering to both urban and semi-urban populations.
Business Model and Services
The company offers integrated healthcare services, including:
-
- Secondary (surgical) care
-
- Tertiary (super-speciality surgical) care
-
- Diagnostic services
-
- Pharmacy operations
Think of it as a one-stop healthcare ecosystem rather than just a hospital chain.
Hospital Network and Infrastructure
-
- Total beds: 400
-
- Approved beds: 355
-
- Operational beds: 250
This indicates strong scope for scaling operations without heavy incremental capital expenditure in the near term.
Presence Across Gujarat
Instead of chasing metro cities blindly, Gujarat Kidney focuses on underpenetrated healthcare markets—a smart strategy where demand is high and competition is relatively low.
